NCT05917951View on ClinicalTrials.gov

Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China

CompletedOBSERVATIONAL

Enrollment

248

Participants

Timeline

Start Date

December 24, 2022

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions

COVID-19

Trial Locations (1)

Unknown

(2) Ruijin-Hainan Hospital Shanghai Jiaotong University School of Medicine (Hainan Boao Research Hospital), Qionghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY